Clin2
NCT04772456Possibly a fitRecruiting

MRI scan using a special sugar to study infiltrating brain tumors

Glioma

Treatments studied

Part of Cancer clinical trials.

This early study (Phase 1) tests a new kind of MRI that uses a special labeled sugar (pyruvate) to help learn how infiltrating gliomas behave in the brain. If you have a suspected or known infiltrating glioma and are having brain surgery or biopsy, this may help your doctors learn more about tumor metabolism and guide future care.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
5 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 80 years old
  • You have a new brain lesion that doctors think could be an infiltrating glioma, or you already have one and are scheduled for surgery (biopsy or resection)
  • You can have a contrast-enhanced MRI (it uses dye in an IV to improve images)
  • If you can become pregnant, you must have a negative pregnancy blood test
  • You must be able to lie in and complete an MRI scan
  • You must be able to safely receive IV contrast (no severe past contrast reaction and no serious kidney problems)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03739411Recruiting· Phase 1
MRI scan with a special agent to assess brain tumors

This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.

San Francisco, California
NCT06594315Recruiting
Brain metabolism scan using deuterated glucose for glioma patients

This study uses a special sugar drink (deuterated glucose) and an MRI-like scan to measure brain metabolism. It aims to better understand how brain tumors use energy, which could help with treatment decisions in the future.

San Francisco, California
NCT00870129Recruiting
MRI mapping to plan radiation for certain brain tumors

This study uses MRI scans to find higher-risk areas in certain brain and other solid tumors and help plan radiation treatment. It also looks for changes in tumor “metabolites” (chemicals in the tumor) that may relate to how the tumor behaves.

New York, New York
NCT07778979Not yet recruiting· Early Phase 1
PET/MRI scans to map brain tumor activity

This study uses special PET and MRI scans to map the activity and oxygen levels of brain tumors (gliomas). The results help doctors plan treatment that is more tailored to each patient.

Birmingham, Alabama
NCT03684109Recruiting
MRI scans to study brain tumors using molecular imaging

This study uses special MRI scans to better “characterize” (study) gliomas, a type of brain tumor, using information from your brain tissue. You may be eligible if you’re an adult with a suspected or confirmed glioma and you already need a biopsy or surgery.

Miami, Florida
NCT05697406Recruiting· Phase 1/Phase 2
Uses MRI to study tumors in people with cancer

This early study tests how well MRI (a type of scan) can help measure a substance related to tumors. If you already have cancer and are able to have an MRI scan, you may be able to take part.

Baltimore, Maryland

Hear when a new Glioma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.